share_log

中国再生医学(08158.HK):曾浩贤辞任非执行董事

CRMI (08158.HK): Zeng Haoxian resigns as non-executive director.

Gelonghui Finance ·  Aug 21, 2024 06:50

China Regenerative Medicine (08158.HK) announced on August 21st that Zeng Haoxian has submitted his resignation as a non-executive director due to his intention to devote more time and energy to his other personal businesses, effective from August 20, 2024. After Zeng Haoxian's resignation, he will no longer be a member of the remuneration committee under the board of directors.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment